We recommend that a specific anatomic diagnosis of infection requiring emergent source control be identified or excluded as rapidly as possible in patients with sepsis or septic shock, and that any ...

We suggest against using IV hydrocortisone to treat septic shock patients if adequate fluid resuscitation and vasopressor therapy are able to restore hemodynamic stability. If this is not achievable, ...

Sepsis is a global health priority affecting 55 million patients worldwide and causing 11 million deaths annually. Treatment for sepsis may include prompt recognition, source control, antibiotics, ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced results of the Fluid Response Evaluation in Sepsis ...

Time to vasopressor initiation from the first hypotensive episode was not significantly associated with 90-day mortality or vasopressor-free days in patients with septic shock, according to a new ...

Please provide your email address to receive an email when new articles are posted on . SEP-1 is the CMS Severe Sepsis/Septic Shock Management Bundle CMS is planning to transition SEP-1 from a pay-for ...

Sepsis is the body’s extreme reaction to an infection. It causes 11 million deaths annually and is a global health priority affecting 55 million patients worldwide annually. Treatment for sepsis ...

Investigators for this study analyzed outcomes among patients hospitalized with pulmonary arterial hypertension (PAH) who have higher risks of adverse health outcomes, in particular sepsis and septic ...

UPMC researchers aim to determine interventions that can stop the progress of sepsis and septic shock; management protocols for the first six hours after diagnosis; and the long-term outcomes for ...